Dengue Market Research Reports & Industry Analysis
Dengue Industry Research & Market Reports
-
Global Dengue NS1 ELISA Kits Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Dengue NS1 ELISA Kits are diagnostic tools used for the detection ... Read More
-
Dengue Vaccine Market Size, Trends, Analysis, and Outlook By Category (Live Attenuated Vaccines, Chimeric Live Attenuated Vaccines), By Product (CTD-TDV, Others), By Route of Administration (Subcutaneous, Others), By Application (Hospitals and clinic, Government Institutes, Specialty Clinics, Others), By End-User (Healthcare, Others), by Region, Country, Segment, and Companies, 2024-2030
... Clinics, Others), By End-User (Healthcare, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Dengue Vaccine market size is poised to register 13.03% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for ... Read More
-
Neglected Tropical Diseases Diagnosis Market Size, Trends, Analysis, and Outlook By Disease (Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne trematode infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African trypanosomiasis (sleeping sickness), Soil-transmitted helminthiases, Onchocerciasis, Schistosomiasis, Scabies, Snakebite Envenoming, Leishmaniases), By Diagnostic Method (Conventional Method, Molecular/Modern Method), By Service (Centralized Service, POC Service), By End-user (Clinical Labs, Hospitals /Clinics, Home Healthcare), by Region, Country, Segment, and Companies, 2024-2030
... helminthiases, Onchocerciasis, Schistosomiasis, Scabies, Snakebite Envenoming, Leishmaniases), By Diagnostic Method (Conventional Method, Molecular/Modern Method), By Service (Centralized Service, POC Service), By End-user (Clinical Labs, Hospitals /Clinics, Home Healthcare), by Region, Country, Segment, and Companies, 2024-2030 ... Read More
-
Neglected Tropical Diseases Drugs and Vaccines Market Size, Trends, Analysis, and Outlook By Disease (Malaria, Ebola, Dengue, Chagas, Leishmaniasis, Zika Virus), By Product (Drugs, Vaccines), by Region, Country, Segment, and Companies, 2024-2030
... Tropical Diseases Drugs and Vaccines market size is poised to register 4.9% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neglected Tropical ... Read More
-
Neglected Tropical Disease Treatment Market Size, Trends, Analysis, and Outlook By Disease (Dengue, Rabies, Trachoma, Buruli ulcer, Yaws, Leprosy, Chagas disease, Human African trypanosomiasis, Leishmaniases, Soil-transmitted helminthiases, Others), By Product (Drugs, Vaccines), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Neglected Tropical Disease Treatment market size is poised to register 4.94% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
The 2025-2030 World Outlook for Dengue Testing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Dengue Vaccine for Age Group >12 Years
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Neglected Tropical Disease Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Dengue Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Enzyme-Linked-Immunosorbent-Assay-Based (ELISA-Based) Dengue Tests
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Tropical Disease Testing Products
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
Global Dengue Virus Diagnostic Tests Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Dengue Virus Diagnostic Tests is forecast to a readjusted size of US$ 4122.9 million by 2030 with a CAGR of 3.8% during review period. The research report highlights ... Read More
-
Dengue Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... million by 2029, growing at a CAGR of 4.37% during the forecast period (2024-2029). The COVID-19 pandemic substantially impacted the dengue testing market. Dengue viruses and SARS-CoV-2 cause similar symptoms in the early stages of ... Read More
-
Global Dengue Vaccines Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Dengue Vaccines industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Dengue Vaccines. The report also introduces players in the industry ... Read More
-
Diagnostic Specialty Antibodies Market by Antibody (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), Application (Dengue Diagnostics, Hepatitis Diagnosis, HIV Diagnostics), End User - Global Forecast 2024-2030
... USD 23.11 billion in 2023 and expected to reach USD 24.36 billion in 2024, at a CAGR 5.49% to reach USD 33.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Neglected Tropical Disease Treatment Market by Product (Drugs, Vaccines), Types of Diseases (Buruli Ulcer, Chagas Disease, Dengue), Diagnostic Method - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 6.40 billion in 2024, at a CAGR 6.25% to reach USD 9.38 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Dengue Testing Market by Type (Dengue IgG/IgM Rapid Test, ELISA-based Test, Real-Time RT-PCR Test), Component (Instruments & Equipments, Laboratory Consumables, Software & Data Management Solutions), End-User - Global Forecast 2024-2030
... was estimated at USD 499.78 million in 2023 and expected to reach USD 527.02 million in 2024, at a CAGR 5.71% to reach USD 737.69 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Global Forecast 2024-2030
... 30.08 billion in 2023 and expected to reach USD 33.05 billion in 2024, at a CAGR 10.35% to reach USD 59.95 billion by 2030. Global Therapeutic Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Global Dengue Testing Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Dengue Testing industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Dengue Testing. The report also introduces players in the industry ... Read More
-
Diagnostic Specialty Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Antibody (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), By Application (Dengue Diagnostics, HIV Diagnostics, Hepatitis Diagnosis, Infectious Disease Diagnostics, Oncology Diagnostics, Tuberculosis Diagnostics), By End User (Diagnostic Laboratories, Hospitals, Others), By Region, and Competition
... Oncology Diagnostics, Tuberculosis Diagnostics), By End User (Diagnostic Laboratories, Hospitals, Others), By Region, and Competition Global Diagnostic Specialty Antibodies Market is anticipated to project impressive growth in the forecast period. The Global Diagnostic Specialty Antibodies ... Read More
-
Dengue Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 761.6 Million by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2023-2028. Dengue, also known as breakbone fever, is a viral infection that spreads through the bite of an infected Aedes aegypti ... Read More
-
Dengue Fever Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Dengue Fever Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Global Dengue Vaccines Market Research Report 2023(Status and Outlook)
... sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is ... Read More
-
Global Dengue Vaccines Market Research Report 2023(Status and Outlook)
... sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is ... Read More
-
Infectious Disease Diagnostics Market, By Technique ( ELISA, Polymerase Chain Reaction (PCR),Immunoassays, Cell Cultures, Others),By Disease Indication (CNS Infection ,Meningitis, Brain Abscess), Diarrheal Disease ( Shigellosis, Cholera, Enteric/Typhoid Fever),Respiratory Infections(Tuberculosis, Influenza, Bronchitis),Blood Infections(Malaria, Dengue, Infectious Mononucleosis, Others),STDs(Chlamydia, Aids, Syphills, Others)),By End User (Hospitals, Diagnostic Centers, Clinics, Government Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Mononucleosis, Others),STDs(Chlamydia, Aids, Syphills, Others)),By End User (Hospitals, Diagnostic Centers, Clinics, Government Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - ... Read More
Research Assistance
